Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Juan Dupont is active.

Publication


Featured researches published by Juan Dupont.


Cancer Genetics and Cytogenetics | 1986

Translocation (2;3) in hematologic malignancies

Irma Slavutsky; Mabel Labal de Vinuesa; Irene Larripa; Juan Dupont; Sonia Brieux de Salum

Cytogenetic studies have revealed nonrandom involvement of some chromosomes in specific structural abnormalities in human neoplasias. In this report we present three patients with t(2;3) associated with hematologic malignancies, and review the pertinent literature. These findings lead us to regard the region between 3q26 and 3q29 as implicated in chromosomal changes in these disorders, whereas, no vulnerable point has been observed in chromosome #2. We suggest that these translocations may activate genes on chromosome #3 related to these neoplasias.


Cancer Genetics and Cytogenetics | 1981

Abnormalities of chromosome No. 1: Two cases with lymphocytic lymphomas

Irma Slavutsky; Mabel Labal de Vinuesa; Juan Dupont; Nora Mondini; Sonia Brieux de Salum

Abstract Two cases of lymphocytic lymphoma with a duplication of part of the long arm of chromosome #1, between bands 1q25 and 1q32, are presented. The coincidence between this finding with others in the literature supports the concept that this specific chromosome segment is related to the proliferative advantage of malignant cells in neoplasia.


Cancer Genetics and Cytogenetics | 1981

Ph1-negative chronic myelocytic leukemia (CML) with an unusual karyotype☆

Mabel Labal de Vinuesa; Irma Slavutsky; Juan Dupont; Catalina C Bianchi de Di Risio; Sonia Brieux de Salum

Abstract A case of Ph 1 -negative chronic myelocytic leukemia is reported. Cytogenetic analysis and the development of colonies in soft agar culture 2 months before the clinical manifestation of the acute phase of the disease clearly indicated the bad prognosis of the patient. An extra #8 chromosome was found in 23% of his cells. Also of note was the presence of an abnormal clone characterized by t(12;13).


Cancer Genetics and Cytogenetics | 2005

Chronic lymphocytic leukemia developing in a patient with chronic myeloid leukemia: evidence of distinct lineage-associated genomic events

Patricia Gargallo; Roberto Cacchione; Christian Chena; Juan Dupont; Guy Garay; Dardo Riveros; Irene Larripa; Irma Slavutsky


Medicina-buenos Aires | 2006

Oligonucleotide IMT504 induces an immunogenic phenotype and apoptosis in chronic lymphocytic leukemia cells.

Juan M. Rodríguez; Fernanda Elı́as; Alejandro Montaner; Juan Fló; Ricardo A. López; Jorge Zorzopulos; Raul Franco; Silvina P. Lenial; Mariella López Salón; María L. Pirpignani; Jorge Solimano; Guy Garay; Dardo Riveros; José A. Fernández; Roberto Cacchione; Juan Dupont


Lymphatic Research and Biology | 2006

99mTechnetium-SESTAMIBI uptake in malignant lymphomas. Correlation with chemotherapy response.

Alberto Lazarowski; Juan Dupont; José A. Fernández; Guy Garay; Alejo Florín; Jorge Solimano; Dardo Riveros; Roberto Cacchione


Blood | 2008

90 y-Ibritumomab Tiuxetan Treatment for Relapsed and/or Refractory B-Cell Non- Hodgkin’S Lymphoma. Multi-Institutional Argentinian Study. An Update

Roberto Cacchione; Jorge Milone; Javier Bordone; Elsa Nucifora; Juan Dupont; Guy Garay; Dardo Riveros; Alfredo Basso; Silvia Rudoy; Gustavo Milone; Luis Palmer; Daniel Argentieri; Alicia Trouboul; Maria Ardaiz; Marcelo Iabstrebner; Gonzalo Pombo; Alicia Diaz; Roberto Tur; Carlos S. Chiattone; Hugo Krupitzki; Diana Lafalce; Hugo Corradini; Mario Brown Arnold; Carlos Cañellas; Marta Zerga; Antonio Carrasco; Fernando Bezares


Blood | 2008

Coexistence Between Chronic Myeloproliferative Syndrome and Chronic Lymphoproliferative Syndrome: Report of 4 Cases

Marina Huber; Verónica Susana Montero; Dardo Riveros; Guy Garay; José A. Fernández; Juan Dupont; Roberto Cacchione


Blood | 2007

90 Y-Ibritumomab Treatment for Relapsed and/or Refractory B Cell Type Non-Hodgkin’s Lymphoma. Multiinstitutional Argentinian Study.

Roberto Cacchione; Juan Dupont; Jorge Milone; Javier Bordone; Guy Garay; Maria Ardaiz; Miguel Castro-Rios; Virginia Prates; Alfredo Basso; Marcelo Iabstrebner; Graciela Avila; Alicia Diaz; Daniel Argentieri; Silvia Rudoy; Alicia Trouboul; Luis Palmer; Gonzalo Pombo; Silvina Rappaciotti; Pedro Negri; Diana Lafalse; Leandro Riera; Miguel de Tezanos-Pinto; Dardo Riveros; Mario Brown Arnold; Antonio Carrasco; Fernando Bezares


Blood | 2006

A Phase 2 Study of 90 Y-Ibritumomab Tiuxetan ( 90 Y-Zevalin®) in Relapsed/Refractory Non-Hodgkin’s Lymphoma: Preliminary Report of the Argentinean Cooperative Group.

Roberto Cacchione; Jorge Milone; Javier Bordone; Juan Dupont; Gustavo Milone; Dardo Riveros; Pedro Negri; Maria Ardaiz; Leandro Riera; Maria Cecilia Foncuberta; Fernando Bezares

Collaboration


Dive into the Juan Dupont's collaboration.

Top Co-Authors

Avatar

Dardo Riveros

Academia Nacional de Medicina

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Irene Larripa

Academia Nacional de Medicina

View shared research outputs
Top Co-Authors

Avatar

Jorge Milone

Hospital Italiano de Buenos Aires

View shared research outputs
Top Co-Authors

Avatar

Irma Slavutsky

New York Academy of Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Christian Chena

Academia Nacional de Medicina

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Irma Slavutsky

New York Academy of Medicine

View shared research outputs
Researchain Logo
Decentralizing Knowledge